
    
      The study would record patients' medical data at baseline and follow them up for different
      period of time. Updated data would be recorded and blood( or BALF) of the patients would be
      drawn for tests or stored as whole blood or serum at -80â„ƒ when patients visit the hospital.
      Then the cytokine (A panel set by the manufacturer) of the serum and BALF would be tested .
      The secretion ability of peripheral blood mononuclear cells would also be verified. The
      investigators would then analyze the data and see if any cytokine is relative to the
      exacerbation or other indicators of the severity of ABPA.
    
  